Searched for
OPTIMUS DRUGS
Tesla robots take over? Major company snaps up 10,000 units, raising job fears for humansPharmAGRI is set to acquire ten thousand Tesla Optimus robots. These advanced humanoid machines will be integrated into farm operations and...- PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEOKhubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubila...
- PAG-led API Platform acquire controlling stake in OptimusFounded in 2004, Optimus is a vertically integrated manufacturer of pharmaceutical products, including advanced intermediates, active pharm...
- CCI clears deal involving Sekhmet Pharmaventures, Optimus DrugsIn a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as ...
- PAG, partners buy controlling stake in Optimus for Rs 2,000 crorePAG, a leading alternative investment firm focused on Asia-Pacific, along with consortium partners CX Partners and Samara Capital, on Wedne...
- Optimus too could launch Covid pill Paxlovid soonThe company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator ...
- Cipla to conduct study on PaxlovidIn its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cip...
- Nod for Paxlovid's Indian generic version to take longerHetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. Howeve...
- SEC no to clinical trial waiver for Pfizer's Covid pillThe SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...
- MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brandThe group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facil...
- Molnupiravir authorisation comes with a condition - further trials in the next three monthsAccording to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the ...
- Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
- Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyThe firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...
- SEC to review companies' applications for Molnupiravir on MondayThe drug is touted as a game-changer in the fight against the pandemic, and a panel of experts of the US Food and Drug Administration (FDA)...
- Expert panel seeks additional info on Merck's Covid-19 drugMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
- Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...
- Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in IndiaAs the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements th...
- Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
- Local Covid drug makers ramp up capacityThis follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...
Load More
